Coya Therapeutics, Inc.COYANASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+73.5%
5Y CAGR+93.4%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+73.5%/yr
Annual compound
5Y CAGR
+93.4%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
27x
Strong expansion
Streak
5 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $28.18M | +215.3% |
| 2024 | $8.94M | +6.4% |
| 2023 | $8.40M | +55.6% |
| 2022 | $5.40M | +10.9% |
| 2021 | $4.87M | +367.3% |
| 2020 | $1.04M | - |